Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Kinase drug discovery: What's next in the field?
Philip Cohen
,
Dario R. Alessi
Research output
:
Contribution to journal
›
Article
›
peer-review
335
Citations (Scopus)
Overview
Fingerprint
Projects
(3)
Fingerprint
Dive into the research topics of 'Kinase drug discovery: What's next in the field?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Protein Kinase
100%
Kinase Drug Discovery
100%
Signaling Network
50%
Immune System
25%
Dividends
25%
Clinical Trials
25%
Pharmaceutical Industry
25%
Drug Development
25%
Parkinson's Disease
25%
Kinase Activation
25%
Kinase Activity
25%
Pseudokinase
25%
Inflammatory Diseases
25%
Specific Inhibitor
25%
Drug Target
25%
Clinical Application
25%
Signal Transduction Pathway
25%
Protein Kinase Inhibitors
25%
Activating mutation
25%
Chronic Inflammatory Diseases
25%
Hypertension Management
25%
Target Molecule
25%
Drug Class
25%
Hypertension Disease
25%
Leucine-rich Repeat Kinase 2 (LRRK2)
25%
OSR1
25%
MyD88 Signaling
25%
LRRK2 Inhibitors
25%
Chronic Autoimmune Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Phosphotransferase
100%
Protein Kinases
100%
Inflammatory Disease
50%
Malignant Neoplasm
25%
Clinical Trial
25%
Drug Development
25%
Parkinson's Disease
25%
Autoimmune Disease
25%
Myeloid Differentiation Factor 88
25%
Diseases
25%
Protein Kinase Inhibitor
25%